GlassScriptPhysician profile
Nathan Ambrose
NPI 1326694076
$2,074.88
in general payments reported to CMS, 2019-2025
24 companies · $1,014 in 2025
The $1,014 reported for 2025 was more than what 90% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $201 · 2022: $72.94 · 2023: $207 · 2024: $581 · 2025: $1,014.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,801.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,801.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $857.42 | 2024-2025 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $143.65 | 2023-2025 | Lifevest |
| Getinge USA Sales, LLC | $128.06 | 2021 | |
| Medtronic, INC. | $114.57 | 2023-2025 | Endurant Iis, Signia, Hawkone |
| Pacira Pharmaceuticals Incorporated | $114.24 | 2023-2025 | Exparel, Iovera, Zilretta |
| Alon Medical Technology | $92.14 | 2025 | |
| Lsi Solutions INC | $69.05 | 2022-2023 | Cor Knot |
| Merck Sharp & Dohme LLC | $66.16 | 2024-2025 | Keytruda |
| Chiesi USA, INC. | $63.19 | 2021-2022 | |
| Boston Scientific Corporation | $60.19 | 2025 | General - Vascular Intervention |
| Atricure, INC. | $54.07 | 2025 | Atriclip Laa Exclusion System, Atricure Cryoice Cryoablation System (Cryo2), Atricure Cryoice Cryosphere Cryoablation System |
| Eagle Pharmaceuticals, INC. | $51.42 | 2023-2024 | |
| Philips North America LLC | $34.04 | 2023 | |
| Becton, Dickinson and Company | $27.11 | 2024 | Progel Applicator Spray Tips |
| Ethicon US, LLC | $25.93 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $24.24 | 2023 | Mitris Resilia Mitral Valve |
| Ambu INC. | $23.56 | 2024 | |
| La Jolla Pharmaceutical Company | $20.96 | 2024 | Giapreza |
| Artivion, INC. | $19.87 | 2024 | On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder |
| Baxter Healthcare | $19.58 | 2024 | Coseal |
| Intuitive Surgical, INC. | $18.04 | 2021 | |
| Stryker Corporation | $16.68 | 2023 | Na, Stryker Varispeed |
| Silk Road Medical, INC. | $15.52 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Lemaitre Vascular, INC. | $15.19 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Ambrose listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.